

COVID-19 IgG/IgM Rapid Test Cassette Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The COVID-19 IgG/IgM Rapid Test Cassette market research reports highlight the growing demand for rapid testing solutions due to the pandemic. The market size is projected to reach a value of $2.5 billion by 2027. The reports analyze market trends, key players, and challenges in this evolving landscape.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Cellex
◍ Mayo Clinic Laboratories
◍ BioMedomics
◍ Abbott
◍ Safecare Bio-Tech
◍ Roche
◍ Mount Sinai Laboratory
◍ Henry Schein
◍ BD
◍ Chembio Diagnostics
◍ Guangdong Hecin-Scientific
◍ Ortho Clinical Diagnostics
◍ Dynamiker Biotechnology (Tianjin)
◍ Guangzhou Wondfo Biotech
◍ Zhejiang Orient Gene Biotech
◍ ADVAITE
◍ Innovita Biological Technology
The competitive landscape of COVID-19 IgG/IgM Rapid Test Cassette Market includes companies like Cellex, Mayo Clinic Laboratories, BioMedomics, Abbott, and more. These companies provide rapid test cassette products for detecting COVID-19 antibodies. Some of them have seen significant sales revenue growth, with Abbott reporting $32 billion revenue in 2020.
◍ Hospitals
◍ Scientific Research
◍ Rapid Diagnostic Test (RDT)
◍ Enzyme Linked Immunosorbent Assay (ELISA)
◍ Neutralization Assay